Table 2.
Substrate | Substrate dose | Duloxetine dose | Simulated AUCRa | Observed AUCR | R pred/obs | Reference study |
---|---|---|---|---|---|---|
Tolterodine | 2 mg/12 hours, 9 doses | 40 mg/12 hours, 9 doses | 2.85 (2.59–2.94) | 1.71 (1.31–2.23)a | 1.67 | Ref. 16 |
Desipramine | 50 mg SD at day 6 | 30 mg/12 hours, 20 doses | 1.75 (1.62–1.78) | 2.22 (1.95–2.51)b | 0.79 | Ref. 15 |
Metoprolol | 100 mg SD at day 17 | 30 mg day 1 then 60 mg days 2–18 | 1.75 (1.66–1.82) | 2.80 ± 0.31c | 0.63 | Ref. 19 |
AUCR, ratio of the substrate area under the concentration‐time curve in the presence and absence of the inhibitor; R pred/obs, ratio of model‐predicted mean exposure change of substrate to observed value; SD, single dose.
Geometric mean with 95% confidence interval.
Geometric mean with 90% confidence interval.
Arithmetic mean ± standard deviation.